Literature DB >> 18836732

[Evidence-based recommendations for the treatment of fibromyalgia syndrome].

P Harten1, E Genth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 18836732     DOI: 10.1007/s00393-008-0379-1

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  6 in total

Review 1.  [Fibromyalgia syndrome: new developments in pharmacotherapy].

Authors:  P Harten
Journal:  Z Rheumatol       Date:  2008-02       Impact factor: 1.372

2.  A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder.

Authors:  P Hannonen; K Malminiemi; U Yli-Kerttula; R Isomeri; P Roponen
Journal:  Br J Rheumatol       Date:  1998-12

Review 3.  Exercise for treating fibromyalgia syndrome.

Authors:  A J Busch; K A R Barber; T J Overend; P M J Peloso; C L Schachter
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 4.  EULAR evidence-based recommendations for the management of fibromyalgia syndrome.

Authors:  S F Carville; L Arendt-Nielsen; S Arendt-Nielsen; H Bliddal; F Blotman; J C Branco; D Buskila; J A P Da Silva; B Danneskiold-Samsøe; F Dincer; C Henriksson; K G Henriksson; E Kosek; K Longley; G M McCarthy; S Perrot; M Puszczewicz; P Sarzi-Puttini; A Silman; M Späth; E H Choy
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

Review 5.  Management of fibromyalgia syndrome.

Authors:  Don L Goldenberg; Carol Burckhardt; Leslie Crofford
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

Review 6.  Biology and therapy of fibromyalgia. New therapies in fibromyalgia.

Authors:  Lesley M Arnold
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.